Obesity and myeloma: Clinical and mechanistic contributions to disease progression
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2023.1118691
Abstract: Obesity and obesogenic behaviors are positively associated with both monoclonal gammopathy of unknown significance (MGUS) and multiple myeloma (MM). As the only known modifiable risk factor, this association has emerged as a new potential target… read more here.
Keywords: myeloma clinical; progression; disease progression; obesity myeloma ... See more keywords